1 0 5

Size: px

Start display at page:

Download "1 0 5"

律蝴秋
9 years ago
Views:

2 1 0 5

5 - -

6 - ( )

7 (1/2) (2/2) ,000 30,000 30,000 50,000 50,000

8 19

9 ( )

10 ( )

13 ( ) () ( ) ()

17 5 7 8

18 11 7, , % % % % 1, ,414 12

21 / / / / / 23 24

24 !!

25 2015 SNQ SNQ SNQ SNQ

26 SCI Different Impacts of α- and β-blockers in Neurogenic Hypertension - The new results will likely help us customize therapies. Hemoglobin 2015(39):81-87 () 43 J Vasc Interv Radiol 2014;25:

30 Health care-associated infections Infections acquired while in the health care setting, with a lack of evidence that the infection was present or incubating at the time of entry into the health care setting Horan TC, et al. Am. J. Infect. Control 36:309

31 Infectious Agent Transmission / Small particle aerosols (droplet nuclei 5μ) Large particles (Droplets 5μ): Susceptible Host /3/20 (airborne precautions) (droplet precautions) (contact precautions) (standard precautions)

32 (airborne precaution) 6-12 (HEPA filter) ( ) (N95) 3~ (droplet precaution) : ( 3 ) (cohorting care) () ~

33 ( ) (MRSA,VRE,CRAB,CRE) :, (cohorting care) ( ) non-critical device( )

34 Sarcopte s scabiei Scabies) : 1. :Benzyl benzoate lotion BB LotionEurax cream 3~7 ** 2.(50 ) : X 為 VRE 培養陽性部位 The Risk of Hand and Glove Contamination after Contact with a VRE (+) Patient Environment. Hayden M, ICAAC, 2001, Chicago, IL.

35 (PPE) (,, ) / PPE,PPE, / / /, / Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings 2007

36 ? ~104 Lancet Infect Dis 2006;6:

37 :

38 / : :

39 1. 2./ ()

40 () CNS , 4. 5.,, 6. : ( - -N95) /

41 N95 (1)( ) (2) : : : : : : : : 1. : ( ) 2./: 3. : : N95 4.: 4 N /3/20

42 N95 N /3/ /3/20 vs PPE Use in Healthcare Settings

43 CDC, Taiwan

44 1. >38 () ( ) 2. 3.( 2 )

45 1 ( ) 2 [email protected]) 66-1

46 -2-3 TOCC- / /3/20 71

47 CDC, Taiwan

48 8 78 (,,..) 0.9%NS Infection control (PPE) ( ) ( ) 1.HBV HCV HIV VDRL Proactive/systemic versus reactive/individual approach Professor Didier Pittet, Geneva

50 -

52 (Zika IgM ~ 12 it b L i P d 2~ % (New Engl J Med Feb 10, 2016 Online First) 80 ()

59 TOCC ry Kaohsiung Veterans General Hospital Tel ext Fax [email protected]

61 ( ) Plan 1 Plan 2 Plan 3 - Plan 4 Plan 5 MDR (DOTS-Plus) Plan 6 Plan 7 Plan 8 Plan 9 Plan 10 Plan 11 Plan 12 Plan 13 Plan 14 & (PETTS DOTS ) Plan 15

62 : DOTS( ) (Direct Observed Treatment, Short Course) DOTS ( ) -- :

63 都治關懷員隨同公衛護士至醫院訪視病人教導病人認識結核病及都治計畫的簡介關懷員送藥到約定地點個案到點服藥關懷員家訪送藥

64 Isoniazid (INH) 9(270 ) 3HP-Isoniazid (INH) + Rifapentine (RPT) 12 3 <13 96% MDR INH RMP

65 WHO 2035

66 ( )

68 ( ) 35

69 37

70 (LIS) (LIS) Source - + Contact - Environment -

71 / X / 10 > > < > < > ( )

72 ( ) HEPA filter ( )

73 ) PCR

74 X X X X

76 v.s 2..

77 ...? (2/22)

78 ? : :,

79 : :

80 ? ( / ) : : : :

81 / //? /??,???????

82 /??,?????,? : : : ( VS)

83 (3/ ) + : vs : :

84 1. 2. :

85 ?? ISO-405-PD-EV V1.0

87 2016/3/ /3/ /3/ /3/20 4

88 2016/3/ /3/ /3/ /3/20 8

89 (1/4) (2/4) 2016/3/ /3/20 10 (3/4) (4/4) 2016/3/ /3/20 12

90 (1/2) (2/2) 2016/3/ /3/20 14 (1/2) (2/2) 2016/3/ /3/20 16

91 2016/3/ /3/20 18 ( ) 2016/3/20 19 (1/2) 2016/3/20 20

92 (2/2) () 2016/3/ /3/ /3/ /3/20 24

93 (1/2) 2016/3/ /3/20 26 (2/2) (1/2) 2016/3/ /3/20 28

94 (2/2) 2016/3/ /3/ /3/20 31

1 2 92 3 4

105 :105.06.27 :2 : 1 2 92 3 4 82 85 88 91 95 98 102 5.97 10.70 5 6 6 921031 11 1031114 7,848.94 2,374.30 7 7 8 90 109 971 48 9 9 10 369 431 1539 547 18.95% 10 102 2 4 53 29 10 44 20 24 77 10 20 (1056)